Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction

Barry A. Boilson, Thomas J. Kiernan, Adriana Harbuzariu, Rebecca E. Nelson, Amir Lerman, Robert D. Simari

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Endothelial dysfunction is an early manifestation of atherosclerotic disease. Circulating cells that express CD34, including endothelial and hematopoietic progenitor cells, might play a part in the development and progression of atherosclerosis. The aim of this study was to evaluate the association between coronary endothelial dysfunction and concentrations of circulating CD34+ cell subsets. Methods: Intracoronary acetylcholine challenge was used to test for coronary endothelial dysfunction in 57 consecutive patients scheduled to undergo diagnostic coronary angiography and with no signs of substantial obstructive lesions. Mononuclear cells were extracted from whole blood samples taken from all patients, analyzed by flow cytometry for CD14, CD34, CD133, CD45, and vascular endothelial growth factor receptor 2 (VEGFR2), and cultured for functional analysis. Results: Compared with patients with normal coronary endothelial function, in those with coronary endothelial dysfunction, the number of circulating CD34+/CD45dim/VEGFR2- cells, CD34+/CD45dim/CD133+/ VEGFR2- cells and colony-forming units were reduced. Concentrations of CD34+/CD45-/VEGFR2+ cells did not differ between groups. Conclusions: Regulation of CD34+ cell subsets seems to differ between patients with coronary endothelial dysfunction and those with normal coronary endothelial function. Changes in specific circulating progenitor cell subsets might, therefore, be an early manifestation of atherosclerosis.

Original languageEnglish (US)
Pages (from-to)489-496
Number of pages8
JournalNature Clinical Practice Cardiovascular Medicine
Volume5
Issue number8
DOIs
StatePublished - Aug 2008

Fingerprint

Vascular Endothelial Growth Factor Receptor-2
Atherosclerosis
Stem Cells
Hematopoietic Stem Cells
Coronary Angiography
Acetylcholine
Flow Cytometry

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. / Boilson, Barry A.; Kiernan, Thomas J.; Harbuzariu, Adriana; Nelson, Rebecca E.; Lerman, Amir; Simari, Robert D.

In: Nature Clinical Practice Cardiovascular Medicine, Vol. 5, No. 8, 08.2008, p. 489-496.

Research output: Contribution to journalArticle

Boilson, Barry A. ; Kiernan, Thomas J. ; Harbuzariu, Adriana ; Nelson, Rebecca E. ; Lerman, Amir ; Simari, Robert D. / Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. In: Nature Clinical Practice Cardiovascular Medicine. 2008 ; Vol. 5, No. 8. pp. 489-496.
@article{e13bc87e8298401c87dd4fd4fe861230,
title = "Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction",
abstract = "Background: Endothelial dysfunction is an early manifestation of atherosclerotic disease. Circulating cells that express CD34, including endothelial and hematopoietic progenitor cells, might play a part in the development and progression of atherosclerosis. The aim of this study was to evaluate the association between coronary endothelial dysfunction and concentrations of circulating CD34+ cell subsets. Methods: Intracoronary acetylcholine challenge was used to test for coronary endothelial dysfunction in 57 consecutive patients scheduled to undergo diagnostic coronary angiography and with no signs of substantial obstructive lesions. Mononuclear cells were extracted from whole blood samples taken from all patients, analyzed by flow cytometry for CD14, CD34, CD133, CD45, and vascular endothelial growth factor receptor 2 (VEGFR2), and cultured for functional analysis. Results: Compared with patients with normal coronary endothelial function, in those with coronary endothelial dysfunction, the number of circulating CD34+/CD45dim/VEGFR2- cells, CD34+/CD45dim/CD133+/ VEGFR2- cells and colony-forming units were reduced. Concentrations of CD34+/CD45-/VEGFR2+ cells did not differ between groups. Conclusions: Regulation of CD34+ cell subsets seems to differ between patients with coronary endothelial dysfunction and those with normal coronary endothelial function. Changes in specific circulating progenitor cell subsets might, therefore, be an early manifestation of atherosclerosis.",
author = "Boilson, {Barry A.} and Kiernan, {Thomas J.} and Adriana Harbuzariu and Nelson, {Rebecca E.} and Amir Lerman and Simari, {Robert D.}",
year = "2008",
month = "8",
doi = "10.1038/ncpcardio1277",
language = "English (US)",
volume = "5",
pages = "489--496",
journal = "Nature Reviews Cardiology",
issn = "1759-5002",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction

AU - Boilson, Barry A.

AU - Kiernan, Thomas J.

AU - Harbuzariu, Adriana

AU - Nelson, Rebecca E.

AU - Lerman, Amir

AU - Simari, Robert D.

PY - 2008/8

Y1 - 2008/8

N2 - Background: Endothelial dysfunction is an early manifestation of atherosclerotic disease. Circulating cells that express CD34, including endothelial and hematopoietic progenitor cells, might play a part in the development and progression of atherosclerosis. The aim of this study was to evaluate the association between coronary endothelial dysfunction and concentrations of circulating CD34+ cell subsets. Methods: Intracoronary acetylcholine challenge was used to test for coronary endothelial dysfunction in 57 consecutive patients scheduled to undergo diagnostic coronary angiography and with no signs of substantial obstructive lesions. Mononuclear cells were extracted from whole blood samples taken from all patients, analyzed by flow cytometry for CD14, CD34, CD133, CD45, and vascular endothelial growth factor receptor 2 (VEGFR2), and cultured for functional analysis. Results: Compared with patients with normal coronary endothelial function, in those with coronary endothelial dysfunction, the number of circulating CD34+/CD45dim/VEGFR2- cells, CD34+/CD45dim/CD133+/ VEGFR2- cells and colony-forming units were reduced. Concentrations of CD34+/CD45-/VEGFR2+ cells did not differ between groups. Conclusions: Regulation of CD34+ cell subsets seems to differ between patients with coronary endothelial dysfunction and those with normal coronary endothelial function. Changes in specific circulating progenitor cell subsets might, therefore, be an early manifestation of atherosclerosis.

AB - Background: Endothelial dysfunction is an early manifestation of atherosclerotic disease. Circulating cells that express CD34, including endothelial and hematopoietic progenitor cells, might play a part in the development and progression of atherosclerosis. The aim of this study was to evaluate the association between coronary endothelial dysfunction and concentrations of circulating CD34+ cell subsets. Methods: Intracoronary acetylcholine challenge was used to test for coronary endothelial dysfunction in 57 consecutive patients scheduled to undergo diagnostic coronary angiography and with no signs of substantial obstructive lesions. Mononuclear cells were extracted from whole blood samples taken from all patients, analyzed by flow cytometry for CD14, CD34, CD133, CD45, and vascular endothelial growth factor receptor 2 (VEGFR2), and cultured for functional analysis. Results: Compared with patients with normal coronary endothelial function, in those with coronary endothelial dysfunction, the number of circulating CD34+/CD45dim/VEGFR2- cells, CD34+/CD45dim/CD133+/ VEGFR2- cells and colony-forming units were reduced. Concentrations of CD34+/CD45-/VEGFR2+ cells did not differ between groups. Conclusions: Regulation of CD34+ cell subsets seems to differ between patients with coronary endothelial dysfunction and those with normal coronary endothelial function. Changes in specific circulating progenitor cell subsets might, therefore, be an early manifestation of atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=48349106118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48349106118&partnerID=8YFLogxK

U2 - 10.1038/ncpcardio1277

DO - 10.1038/ncpcardio1277

M3 - Article

C2 - 18578002

AN - SCOPUS:48349106118

VL - 5

SP - 489

EP - 496

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

SN - 1759-5002

IS - 8

ER -